STOCK TITAN

Solventum (NYSE: SOLV) CHRO exercises 4,342 RSUs, withholds shares

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Solventum Corp reported an insider equity transaction by its Chief Human Resources Officer, Tammy L. Gomez. On 01/02/2026, she acquired 4,342 shares of Solventum common stock through the settlement of restricted stock units. On the same date, 1,332 shares were disposed of at $79.2 per share, typically reflecting shares withheld to cover taxes.

After these transactions, Gomez directly beneficially owned 8,665 shares of Solventum common stock. The filing explains that each RSU converts into one share of common stock upon settlement, and that the RSUs vest in three equal annual tranches on the first, second, and third anniversaries of the grant date, subject to continued service.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gomez Tammy L

(Last) (First) (Middle)
2510 CONWAY AVENUE
3M CENTER BLDG. 275-6W

(Street)
MAPLEWOOD MN 55144

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Human Resources Officer
3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/02/2026 M 4,342 A (1) 9,997 D
Common Stock 01/02/2026 F 1,332 D $79.2 8,665 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 01/02/2026 M 4,342 (2) 01/02/2034 Common Stock 4,342 $0 4,342 D
Explanation of Responses:
1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
2. The RSUs shall fully vest in three tranches, with one-third vesting on each of the first, second and third anniversaries of the grant date, subject to continued service through the vesting date.
Remarks:
/s/Matthew Rice, attorney-in-fact for Tammy L. Gomez 01/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Solventum (SOLV) report in this Form 4?

The filing reports that Chief Human Resources Officer Tammy L. Gomez settled restricted stock units into 4,342 shares of Solventum common stock on 01/02/2026, with a portion of the shares disposed of the same day.

How many Solventum (SOLV) shares did the insider acquire and dispose of?

On 01/02/2026, Gomez acquired 4,342 shares of common stock and disposed of 1,332 shares, which were recorded at a price of $79.2 per share.

How many Solventum (SOLV) shares does the insider own after the reported transaction?

Following the reported transactions, Tammy L. Gomez beneficially owned 8,665 shares of Solventum common stock in direct ownership.

What are the terms of the Solventum (SOLV) restricted stock units in this filing?

Each restricted stock unit, or RSU, represents a contingent right to receive 1 share of Solventum common stock upon settlement. The RSUs vest in three tranches, with one-third vesting on each of the first, second, and third anniversaries of the grant date, subject to continued service.

What does the $79.2 price in the Solventum (SOLV) Form 4 represent?

The $79.2 price is associated with the disposition of 1,332 shares of Solventum common stock on 01/02/2026, reflecting the value used for those shares in the transaction.

What role does the reporting person hold at Solventum (SOLV)?

The reporting person, Tammy L. Gomez, is identified as Solventum’s Chief Human Resources Officer and an officer of the issuer.

How do the Solventum (SOLV) RSUs convert into common stock?

According to the filing, each RSU converts into one share of Solventum common stock upon settlement after vesting, assuming the service-based vesting conditions are met.

Solventum Corporation

NYSE:SOLV

SOLV Rankings

SOLV Latest News

SOLV Latest SEC Filings

SOLV Stock Data

13.95B
147.58M
14.9%
66.72%
2.46%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
ST. PAUL